IMMERGE BIOTHERAPEUTICS INC has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are EGENESIS INC, SHANGHAI GENON BIOENGINEERING CO LTD and TRANSGENIC INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Animal care | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Hawley Robert J | 7 |
#2 | Patience Clive | 4 |
#3 | Oldmixon Beth A | 3 |
#4 | Ericsson Thomas | 2 |
#5 | Prather Randall S | 2 |
#6 | Day Billy N | 2 |
#7 | Ericsson Thomas A | 1 |
Publication | Filing date | Title |
---|---|---|
AU2012227227A1 | Knockout swine and methods for making the same | |
AU2003265415A1 | Alpha(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND Alpha(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM | |
WO02086060A2 | Molecular sequence of pig endogenous retrovirus receptors and methods of use |